Purisys
a DEA-licensed (Schedule I-V) bulk manufacturer of ultra-high-purity CBD/THC isolates under FDA Drug Master File and GMP certification, recently acquired by Siegfried, a global pharmaceutical CDMO.
- Country
- United States
gmp
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic cannabinoids (CBD & THC) | specialty-fine-chem | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.